The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.Maotai Group had an exchange discussion with Huawei. Kweichow Moutai official news on December 13th. On December 12th, Zhang Pingan, managing director of Huawei Technologies Co., Ltd. and CEO of Huawei Cloud, visited Maotai and held an exchange discussion with Zhang Deqin, Party Secretary and Chairman of Maotai Group.Kangxinuo said on the interactive platform that the company is promoting the research and development of a variety of innovative vaccines, submitting applications for related matters in accordance with the guiding principles of CDE, and actively communicating and reporting.
Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.The application direction of AI fell in early trading, with Jincai Internet falling more than 8%, followed by Tianyu Digital, Huayang Lianzhong, Fushi Holdings, Aofei Entertainment and Fengyuzhu.The concept of starting economy continued to strengthen, and the direction of exhibition and IP economy led the rise. Miao Exhibition, Liard and Guangbo shares rose daily, Fengshang Culture and Zhongqingbao rose by more than 10%, and Tianxiaxiu, Dafeng Industry, Silk Road Vision and Aoya shares were among the top gainers.
Putin: China has made great strides in technological development. According to a report by the Tass news agency on December 11th, Russian President Vladimir Putin said at the international conference on "Journey of Artificial Intelligence" on December 11th that China is making great strides in technological development. According to the report, Putin pointed out in a dialogue with Song Haitao, president of Shanghai Institute of Artificial Intelligence: "China is making great strides in technological development and application of the most important technological development tools. Of course, the artificial intelligence you study is one of the most important tools. " Song Haitao told Putin that the Shanghai Institute of Artificial Intelligence plans to sign a memorandum of cooperation with the Russian Federal Savings Bank to promote technical research in the field of artificial intelligence. Putin said: "I am very happy to hear that you are going to sign a contract with the Russian Federal Savings Bank. I think this is meaningful for you and the Russian Federal Savings Bank. " (World Wide Web)Most gold stocks in Hong Kong stocks fell, and Lingbao Gold fell by nearly 5%. As of press time, Lingbao Gold (03330.HK) fell by 4.75%, Zijin Mining (02899.HK) fell by 2.82% and Zhaojin Mining (01818.HK) fell by 2.75%.The three major stock indexes opened lower, with the Shanghai Composite Index down 0.54%, the Shenzhen Component Index down 0.74% and the Growth Enterprise Market down 0.87%.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14